Assoc. Prof Selen Kanar Verified

Verified specialist profile with transparent experience and patient feedback.

Selen Kanar
  • Medical Unit: Eye Diseases
  • Turkey, Istanbul
  • 14+ Years Experience
  • 0.0
    (0 reviews)

Assoc. Prof. Selen Kanar is an ophthalmologist and retina specialist at Acibadem Maslak Hospital, with Acibadem since 2025. A 2011 graduate of Trakya University, she trained at Fatih Sultan Mehmet Training and Research Hospital and completed a Euretina fellowship in the vitreoretinal surgery and medical retina department of St Thomas' Hospital, London, in 2022, the year she became associate professor. She treats retinal tears and detachment, cataract and glaucoma.

Professional Profile

+About

Assoc. Prof. Selen Kanar is an ophthalmologist and retina specialist at Acibadem Maslak Hospital, with Acibadem since 2025. A 2011 graduate of Trakya University, she trained at Fatih Sultan Mehmet Training and Research Hospital and completed a Euretina fellowship in the vitreoret...

Assoc. Prof. Selen Kanar is an ophthalmologist and retina specialist at Acibadem Maslak Hospital, with Acibadem since 2025. A 2011 graduate of Trakya University, she trained at Fatih Sultan Mehmet Training and Research Hospital and completed a Euretina fellowship in the vitreoretinal surgery and medical retina department of St Thomas' Hospital, London, in 2022, the year she became associate professor. She treats retinal tears and detachment, cataract and glaucoma.

+Education

  • 2011 - Trakya University Faculty of Medicine (MD)
  • 2016 - Fatih Sultan Mehmet Training and Research Hospital - Ophthalmology specialization
  • 2022 - St Thomas' Hospital, London (UK) - Euretina fellowship programme
  • 2022 - Associate Professor of Ophthalmology, Health Sciences University Kartal Dr. Lütfi Kırdar Training and Research Hospital
  • 2011 - Trakya University Faculty of Medicine (MD)
  • 2016 - Fatih Sultan Mehmet Training and Research Hospital - Ophthalmology specialization
  • 2022 - St Thomas' Hospital, London (UK) - Euretina fellowship programme
  • 2022 - Associate Professor of Ophthalmology, Health Sciences University Kartal Dr. Lütfi Kırdar Training and Research Hospital

+Experience

  • 2025-present - Acibadem Healthcare Group (Acibadem Maslak Hospital, Ophthalmology)
  • 2022-2024 - Health Sciences University Kartal Dr. Lütfi Kırdar Training and Research Hospital - Associate Professor
  • 2022 - St Thomas' Hospital, Vitreoretinal Surgery and Medical Retina Department, London (UK)
  • 2018-2022 - Health Sciences University Kartal Dr. Lütfi Kırdar Training and Research Hospital - Specialist
  • 2016 - Ağrı State Hospital - Specialist
  • 2012-2016 - Fatih Sultan Mehmet Training and Research Hospital - Resident
  • 2025-present - Acibadem Healthcare Group (Acibadem Maslak Hospital, Ophthalmology)
  • 2022-2024 - Health Sciences University Kartal Dr. Lütfi Kırdar Training and Research Hospital - Associate Professor
  • 2022 - St Thomas' Hospital, Vitreoretinal Surgery and Medical Retina Department, London (UK)
  • 2018-2022 - Health Sciences University Kartal Dr. Lütfi Kırdar Training and Research Hospital - Specialist
  • 2016 - Ağrı State Hospital - Specialist
  • 2012-2016 - Fatih Sultan Mehmet Training and Research Hospital - Resident

+Memberships

  • European Society of Retina Specialists (EURETINA)
  • EURETINA Young Ophthalmologists
  • Turkish Ophthalmological Association

+Research

  • Retinal tears and retinal detachment
  • Diabetic macular edema and intravitreal injection treatment
  • Retinal vein and retinal artery occlusion
  • Retinitis pigmentosa and vision rehabilitation
  • Cataract and glaucoma

+International Papers

Kıvrak U, Arsan AK, Akçay G, et al. Clinical features, management and outcomes of patients with sterile endophthalmitis associated with intravitreal bevacizumab injection: retrospective case series. Int Ophthalmol. 2024;44:216. Limon U, et al. One-year functional and morphologica...

  • Kıvrak U, Arsan AK, Akçay G, et al. Clinical features, management and outcomes of patients with sterile endophthalmitis associated with intravitreal bevacizumab injection: retrospective case series. Int Ophthalmol. 2024;44:216.
  • Limon U, et al. One-year functional and morphological prognosis after intravitreal injection treatments according to different morphological patterns of diabetic macular edema in real life: MARMASIA Study Group Report No. 13. Semin Ophthalmol. 2024;39(6):460-467.
  • Tokuç EÖ, Karabaş VL, Sevik MO, et al. Efficacy of ranibizumab and aflibercept on reducing maximum diameter of largest cyst in diabetic cystoid macular edema: MARMASIA study group. Eur J Ophthalmol. 2024.
  • Gökçe GD, Kanar HS, Bulut MN, Şimşek Ş. Comparison of the effects of telescopic glasses and filtered glasses on functional vision rehabilitation outcomes in patients with retinitis pigmentosa. Retina-Vitreus. 2024;33(2).
  • Kanar BG, Kanar HS, Ataş H. Evaluation of left ventricular functions in patients with retinal vein occlusion. Medicine Science. 2019.
Turkey - Istanbul Selen Kanar
Open in Google Maps

Facility Amenities & Services

Premises

Parking
Accessible to disabled people
Public transport access
Wheelchair accessible toilet
Access without steps
Disabled parking
Patient bathroom
Wireless access
On-site pharmacy

Patient reviews

0.0
Poor
0 patient verified reviews
5 stars
0%
4 stars
0%
3 stars
0%
2 stars
0%
1 star
0%
Your trust is our top concern

We value your trust above all, so clinics can't pay to alter or remove reviews.

Learn more about reviews.
×
Get a Free Consultation

International Clinics Guarantees

  • Reliable medical care provided within our accredited facilities
  • Final fixed price with no hidden costs
  • Full medical support with professional interpreters
  • Clear treatment plans and follow-up at international standards
  • Personalized assistance throughout the entire treatment journey
  • Confidential handling of all medical information
✓
Success!
Your message has been sent successfully.

Sensitive Content Warning

This image contains sensitive medical content that may not be suitable for all audiences. Do you want to continue viewing?